Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 271

1.

Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

Van Cutsem E, Cervantes A, Nordlinger B, Arnold D; ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii1-iii9. doi: 10.1093/annonc/mdu260. Epub 2014 Sep 4. No abstract available.

PMID:
25190710
[PubMed - in process]
2.

Management of patients over 80 years of age treated with resection for localised colon cancer: Results from a French referral centre.

Lièvre A, Laurent V, Cudennec T, Peschaud F, Malafosse R, Benoist S, Penna C, Lepère C, Vaillant JN, Julié C, Teillet L, Nordlinger B, Rougier P, Mitry E.

Dig Liver Dis. 2014 Sep;46(9):838-45. doi: 10.1016/j.dld.2014.05.005. Epub 2014 Jun 5.

PMID:
24908573
[PubMed - in process]
3.

Minimally-invasive approach for rectal cancer surgery.

Brouquet A, Nordlinger B.

Lancet Oncol. 2014 Jun;15(7):680-1. doi: 10.1016/S1470-2045(14)70233-5. Epub 2014 May 15. No abstract available.

PMID:
24837214
[PubMed - indexed for MEDLINE]
4.

Reply to Letter: "Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)"

Sorbye H, Mauer M, Nordlinger B.

Ann Surg. 2014 Mar 18. [Epub ahead of print] No abstract available.

PMID:
24646558
[PubMed - as supplied by publisher]
5.

Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983.

Tanis E, Nordlinger B, Mauer M, Sorbye H, van Coevorden F, Gruenberger T, Schlag PM, Punt CJ, Ledermann J, Ruers TJ.

Eur J Cancer. 2014 Mar;50(5):912-9. doi: 10.1016/j.ejca.2013.12.008. Epub 2014 Jan 7.

PMID:
24411080
[PubMed - indexed for MEDLINE]
6.

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandalà M, Cervantes A, Arnold D; ESMO Guidelines Working Group.

Ann Oncol. 2013 Oct;24 Suppl 6:vi64-72. doi: 10.1093/annonc/mdt354. No abstract available.

PMID:
24078664
[PubMed - indexed for MEDLINE]
7.

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Mauer M, Tanis E, Van Cutsem E, Scheithauer W, Gruenberger T; EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und–tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD).

Lancet Oncol. 2013 Nov;14(12):1208-15. doi: 10.1016/S1470-2045(13)70447-9. Epub 2013 Oct 11.

PMID:
24120480
[PubMed - indexed for MEDLINE]
8.

Multicenter validation study of pathologic response and tumor thickness at the tumor-normal liver interface as independent predictors of disease-free survival after preoperative chemotherapy and surgery for colorectal liver metastases.

Brouquet A, Zimmitti G, Kopetz S, Stift J, Julié C, Lemaistre AI, Agarwal A, Patel V, Benoist S, Nordlinger B, Gandini A, Rivoire M, Stremitzer S, Gruenberger T, Vauthey JN, Maru DM.

Cancer. 2013 Aug 1;119(15):2778-88. doi: 10.1002/cncr.28097. Epub 2013 Apr 23.

PMID:
23868456
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

[Tolerance and efficacy of preoperative radiation therapy for elderly patients treated for rectal cancer].

Le Fur E, Chatellier G, Berger A, Emile JF, Dousset B, Nordlinger B, Berges O, Deberne M, Dessard-Diana B, Henni M, Giraud P, Housset M, Durdux C.

Cancer Radiother. 2013 Jun;17(3):202-7. doi: 10.1016/j.canrad.2013.01.013. Epub 2013 May 2. French.

PMID:
23643361
[PubMed - indexed for MEDLINE]
10.

Response of liver metastases to preoperative radiochemotherapy in patients with locally advanced rectal cancer and resectable synchronous liver metastases.

Manceau G, Brouquet A, Bachet JB, Penna C, El Hajjam M, Rougier P, Nordlinger B, Benoist S.

Surgery. 2013 Sep;154(3):528-35. doi: 10.1016/j.surg.2013.02.010. Epub 2013 Apr 16.

PMID:
23601902
[PubMed - indexed for MEDLINE]
11.

Metastatic colorectal cancer outcome and fatty liver disease.

Brouquet A, Nordlinger B.

Nat Rev Gastroenterol Hepatol. 2013 May;10(5):266-7. doi: 10.1038/nrgastro.2013.53. Epub 2013 Apr 9. Review.

PMID:
23567218
[PubMed - indexed for MEDLINE]
12.

Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement.

Schwarz RE, Berlin JD, Lenz HJ, Nordlinger B, Rubbia-Brandt L, Choti MA.

HPB (Oxford). 2013 Feb;15(2):106-15. doi: 10.1111/j.1477-2574.2012.00558.x. Epub 2012 Sep 24.

PMID:
23297721
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Surgical strategies to synchronous colorectal liver metastases.

Brouquet A, Nordlinger B.

Dig Dis. 2012;30 Suppl 2:132-6. doi: 10.1159/000342043. Epub 2012 Nov 23. Review.

PMID:
23207945
[PubMed - indexed for MEDLINE]
14.

Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor.

Allard MA, Bachet JB, Beauchet A, Julie C, Malafosse R, Penna C, Nordlinger B, Emile JF.

Diagn Pathol. 2012 Nov 13;7:156. doi: 10.1186/1746-1596-7-156.

PMID:
23148481
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer.

Roth AD, Delorenzi M, Tejpar S, Yan P, Klingbiel D, Fiocca R, d'Ario G, Cisar L, Labianca R, Cunningham D, Nordlinger B, Bosman F, Van Cutsem E.

J Natl Cancer Inst. 2012 Nov 7;104(21):1635-46. doi: 10.1093/jnci/djs427. Epub 2012 Oct 25. Erratum in: J Natl Cancer Inst. 2013 Jan 16;105(2):151-2.

PMID:
23104212
[PubMed - indexed for MEDLINE]
Free Article
16.

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde CJ, Balmana J, Regula J, Nagtegaal ID, Beets-Tan RG, Arnold D, Ciardiello F, Hoff P, Kerr D, Köhne CH, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard JY, El Ghazaly H, Gallardo J, Garin A, Glynne-Jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A.

Ann Oncol. 2012 Oct;23(10):2479-516.

PMID:
23012255
[PubMed - indexed for MEDLINE]
Free Article
17.

The role of biological agents in the resection of colorectal liver metastases.

Nordlinger B, Adam R, Arnold D, Zalcberg JR, Gruenberger T.

Clin Oncol (R Coll Radiol). 2012 Aug;24(6):432-42. doi: 10.1016/j.clon.2012.01.002. Review.

PMID:
22794325
[PubMed - indexed for MEDLINE]
18.

Complete calcification of colorectal liver metastases on imaging after chemotherapy does not indicate sterilization of disease.

Goyer P, Benoist S, Julié C, Hajjam ME, Penna C, Nordlinger B.

J Visc Surg. 2012 Aug;149(4):e271-4. doi: 10.1016/j.jviscsurg.2012.03.002. Epub 2012 May 25.

PMID:
22633572
[PubMed - indexed for MEDLINE]
19.

Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004).

Ruers T, Punt C, Van Coevorden F, Pierie JP, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA, Mauer M, Van Cutsem E, Lutz MP, Nordlinger B; EORTC Gastro-Intestinal Tract Cancer Group, Arbeitsgruppe Lebermetastasen und—tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO) and the National Cancer Research Institute Colorectal Clinical Study Group (NCRI CCSG).

Ann Oncol. 2012 Oct;23(10):2619-26. Epub 2012 Mar 19.

PMID:
22431703
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983).

Sorbye H, Mauer M, Gruenberger T, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Van Cutsem E, Scheithauer W, Lutz MP, Nordlinger B; EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK (CRUK); Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD).

Ann Surg. 2012 Mar;255(3):534-9. doi: 10.1097/SLA.0b013e3182456aa2.

PMID:
22314329
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk